Key facts: France
| Main buyers | UniHA, Resah and AGEPS (AP-HP); regional hospital groups (GHT); UGAP for some categories |
|---|---|
| Main routes | Framework agreements (accords-cadres) and marchés by lot, often national in scope; regional GHT tenders |
| Typical term | Usually two to four years including renewals; frameworks run up to four years by law |
| Award model | Multi-criteria: price with quality, supply security and service, plus at least one environmental criterion since August 2026 |
How do French hospitals buy medicines?
Most public hospitals no longer tender alone. They pool demand through national purchasing groups, which run large tenders by lot for hundreds of establishments, and through the GHT, which consolidate purchasing within each territory. UniHA alone buys several billion euros a year.
The result is fewer, larger awards. A single national lot can set the price and the supplier for a molecule across much of the public hospital sector for several years.
What wins a French tender?
Price is rarely the only criterion. Buyers weigh quality, supply reliability, packaging and service, and since 22 August 2026 at least one award criterion must be environmental. To secure supply, more lots are now awarded to more than one supplier, and supply failures carry penalties.
Appel d'offres, accord-cadre and avis d'attribution
A purchasing group publishes each appel d'offres by lot, usually as an accord-cadre that runs for up to four years, with marchés subséquents or orders placed during the term. The holder of each lot is the titulaire.
The result appears as an avis d'attribution naming the titulaire per lot, often with a maximum or estimated amount instead of a unit price. Losing bidders receive the reasons for rejection and can ask for the characteristics and relative advantages of the winning offer.
How does RGS help in France?
We follow national and regional hospital tenders, capture lot-level awards and criteria weightings, and map which purchasing group buys what. You see when your molecules come up and who holds them today.
What is public in France, and what is not
Tender notices and award notices with the winner's name are published, and larger contracts also publish the winner, amount and duration as open data. For framework agreements that amount is usually a maximum or estimate, not a unit price.
Unit prices are usually not published. National confidential rebates and price-volume clauses agreed with the pricing committee are never public, and neither are small direct purchases below the tender thresholds.
Questions about France
Are retail generics tendered in France?
No. Retail medicine prices in France are set nationally. Tendering applies mainly to hospital medicines, bought through purchasing groups and regional hospital groups.
Do French medicine tenders need an environmental criterion?
Yes. Since 22 August 2026 every public contract must include at least one environmental award criterion.
Does an avis d'attribution show the winning price in France?
Usually not as a unit price. The avis d'attribution names the winner per lot and often gives a maximum or estimated amount for the accord-cadre. Losing bidders can ask the buyer for the reasons and for the relative advantages of the winning offer.
Can RGS show confidential contracts and prices in France?
No outside service can, because they are never published. RGS covers what buyers publish. For the confidential part we set up a private pipeline for your company: your own bids, results, buyer correspondence and price lists, loaded next to the public data and visible only to your team.